Search results for " angewandte Wissenschaften::610 Medizin und Gesundheit::616 Krankheiten"

showing 3 items of 3 documents

Models for preterm cortical development using non invasive clinical EEG

2017

AbstractThe objective of this study was to evaluate the piglet and the mouse as model systems for preterm cortical development. According to the clinical context, we used non invasive EEG recordings. As a prerequisite, we developed miniaturized Ag/AgCl electrodes for full band EEG recordings in mice and verified that Urethane had no effect on EEG band power. Since mice are born with a “preterm” brain, we evaluated three age groups: P0/P1, P3/P4 and P13/P14. Our aim was to identify EEG patterns in the somatosensory cortex which are distinguishable between developmental stages and represent a physiologic brain development. In mice, we were able to find clear differences between age groups wit…

0301 basic medicineBrain developmentsomatosensory cortexmouse modelContext (language use)Neurosciences. Biological psychiatry. NeuropsychiatryBiologyElectroencephalographySomatosensory system600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::616 KrankheitenInterhemispheric coherence03 medical and health sciences0302 clinical medicine616medicineCoherence (signal processing)cortical developmentmedicine.diagnostic_testGeneral Neurosciencephase amplitude couplingNon invasivetelemetrycoherence030104 developmental biologypigletfull band eegpretermNeuroscience030217 neurology & neurosurgeryPhase amplitude couplingRegular ArticlesRC321-571Translational Neuroscience
researchProduct

Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data

2018

Background The X-ACT study aims to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1-antihistamines. Methods In X-ACT, a phase III, double-blind, placebo-controlled study, CSU patients (18–75 years) with ≥4 angioedema episodes during the 6 months before inclusion were randomized (1:1) to receive omalizumab 300 mg or placebo every 4 weeks for 28 weeks. Angioedema-related QoL, skin-related QoL impairment, and psychological well-being were assessed. Results Ninety-one patients were randomized and 68 (omalizumab, n=35; placebo, n=33) completed the 28-week treatment period. At baselin…

AdultMalechronic spontaneous urticariamedicine.medical_specialtyAdolescentUrticariaImmunologyOmalizumab600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::616 KrankheitenPlaceboYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRefractoryQuality of lifeInternal medicine616Anti-Allergic AgentsmedicineHumansH1-antihistamine-refractoryImmunology and AllergyDepression (differential diagnoses)AgedAngioedemaAdult patientsbusiness.industryangioedemaDermatology Life Quality IndexMiddle AgedSurgeryquality of life030228 respiratory systemExperimental Allergy and ImmunologyomalizumabOriginal ArticleFemaleORIGINAL ARTICLESH1‐antihistamine‐refractorymedicine.symptombusinessmedicine.drugAllergy
researchProduct

Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender

2019

In obstructive sleep apnea, patients' sleep is fragmented leading to excessive daytime sleepiness and co-morbidities like arterial hypertension. However, traditional metrics are not always directly correlated with daytime sleepiness, and the association between traditional sleep quality metrics like sleep duration and arterial hypertension is still ambiguous. In a development cohort, we analysed hypnograms from mild (n = 213), moderate (n = 235) and severe (n = 277) obstructive sleep apnea patients as well as healthy controls (n = 105) from the European Sleep Apnea Database. We assessed sleep by the analysis of two-step transitions depending on obstructive sleep apnea severity and anthropom…

AdultMalesleep-disordered breathing.medicine.medical_specialtysleepdisordered breathing[SDV]Life Sciences [q-bio]Cognitive Neurosciencesleep dynamicsExcessive daytime sleepinessSettore MED/10 - Malattie Dell'Apparato Respiratorio600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::616 Krankheitenpower-law distribution03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineInternal medicine616HumansMedicineexponential distributionsleep fragmentationStage (cooking)Retrospective StudiesSleep Apnea Obstructivebusiness.industryConfoundingsleep-disordered breathingAge FactorsGender IdentitySleep apneaGeneral MedicineMiddle AgedAnthropometrymedicine.diseaseSleep in non-human animals[SDV] Life Sciences [q-bio]Obstructive sleep apnea030228 respiratory systemsleep dynamicCohortCardiologyFemaleHuman medicinemedicine.symptomSleepbusiness030217 neurology & neurosurgery
researchProduct